Cargando…
The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation
Reprogramming somatic cells to induced pluripotent stem cells (iPSCs) or direct reprogramming to desired cell types are powerful and new in vitro methods for the study of human disease, cell replacement therapy, and drug development. Both methods to reprogram cells are unconstrained by the ethical a...
Autores principales: | Alvarez Palomo, Ana Belen, Lucas, Michaela, Dilley, Rodney J., McLenachan, Samuel, Chen, Fred Kuanfu, Requena, Jordi, Sal, Marti Farrera, Lucas, Andrew, Alvarez, Inaki, Jaraquemada, Dolores, Edel, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449681/ https://www.ncbi.nlm.nih.gov/pubmed/26237380 http://dx.doi.org/10.3390/jcm3020373 |
Ejemplares similares
-
Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration
por: Alvarez Palomo, Ana Belen, et al.
Publicado: (2015) -
mRNA Transfection of Mouse and Human Neural Stem Cell Cultures
por: McLenachan, Samuel, et al.
Publicado: (2013) -
Global Proteomic and Methylome Analysis in Human Induced Pluripotent Stem Cells Reveals Overexpression of a Human TLR3 Affecting Proper Innate Immune Response Signaling
por: Requena, Jordi, et al.
Publicado: (2019) -
Bioengineered Bruch's-like extracellular matrix promotes retinal pigment epithelial differentiation
por: McLenachan, Samuel, et al.
Publicado: (2017) -
Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy
por: Roca, Isart, et al.
Publicado: (2015)